It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

(Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment ... which involve ...

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug Zepbound for ... who took the highest dose ...

(AP) — Shares of Eli Lilly & Company climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound ... to nearly 14% for Wegovy.

On Thursday, the Food and Drug Administration said Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro to ... The lawsuit was put on hold days later after the FDA agreed to ...

Eli Lilly's weight-loss therapy, Zepbound, got the green light from the ... The highest dose of orforglipron led to 14.7% weight loss after 36 weeks in obese patients, data from a mid-stage ...

Dec 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's (LLY.N), opens new tab weight-loss ... the face while sleeping, surgery, as well as losing weight. Zepbound ...